Washington AG Ferguson Sues Seattle-Based Stem Cell Clinic over False Marketing Claims

  • Washington AG Robert Ferguson has sued Seattle-based US Stemology, LLC and its owners (collectively, “Stemology”) for allegedly violating Washington’s Consumer Protection Act by deceptively marketing and providing stem cell treatments to patients for a host of serious medical conditions at its facility, the Seattle Stem Cell Center.
  • According to the Complaint, 107 patients were charged a total of $748,250 by Stemology for treatments claimed to be safe and effective for a wide range of of serious medical conditions, including lupus, traumatic brain injuries, stroke, diabetes, muscular dystrophy, and COVID-19. Stemology allegedly advertised these treatments with testimonials and efficacy claims with no scientific or medical basis, and told patients they were participating in clinical trials supervised by an “Independent Review Board” which was, in fact, operated by a Stemology affiliate. These alleged trials followed no accepted scientific protocols, and provided no meaningful data about efficacy or safety.
  • The lawsuit seeks immediate cessation of all unlawful conduct, full restitution to patients who paid for procedures, and penalties of $12,500 for each violation of the Consumer Protection Act, which includes enhanced penalties for targeting patients suffering from disabilities.